Nearly 10% of the world's most popular counterfeit

  • Detail

The proportion of counterfeit drugs in the world is nearly 10%. Four kinds of drugs will try anti-counterfeit packaging for the first time.

it was learned from the recently held drug anti-counterfeiting and circulation safety forum that at present, counterfeit drugs account for about 5% to 10% of drugs worldwide, and are increasing at a rate of about 13% per year. The new anti-counterfeiting technology of drug packaging can greatly improve the scientific and technological content and objectively alleviate the phenomenon of manufacturing and selling fake drugs. From July to the end of this year, four listed drugs will successively try digital anti-counterfeiting packaging for the first time

Zhang Heyong, President of the China Association for pharmaceutical quality management, said that in recent years, drug counterfeiting has become a major international problem. An important reason for the proliferation of fake and inferior drugs is the disorder of drug circulation. According to the estimates of the World Health Organization and the U.S. Food and drug administration, counterfeit drugs account for about 5% to 10% of drugs worldwide. The proportion in Southeast Asia and other regions may be higher because more and more aircraft components have begun to use advanced polymer composites. Fake drugs are increasing at a rate of about 13% every year. In order to meet the needs of a wide range of users, Zhu Changhao, vice president of the China Pharmaceutical Association, said that although there is no statistical data on the proportion of fake drugs in China at present, fake and inferior drugs have always existed. And counterfeit drugs are mostly concentrated in enterprises with famous brand products, or add high profit products such as human albumin

Zhang Heyong said that drug anti-counterfeiting is becoming a global topic. At present, some domestic manufacturers' drug packaging anti-counterfeiting means are single, the content of science and technology is not high, and the content of printing technology is not high. Some pharmaceutical enterprises' brand protection awareness is not strong, and their products are listed in a hurry without any anti-counterfeiting means. These are objectively easy to cause drugs to be counterfeited

a new digital anti-counterfeiting technology announced at this forum will be piloted in China's drug circulation market in the next six months after buying a low-cost press. It will be initially applied to four products, Nexium tablets, Losec needles, Nexium needles and IRESSA

Copyright © 2011 JIN SHI